Potent Plasmablast-Derived Antibodies Elicited by the National Institutes of Health Dengue Vaccine (2017)
- Authors:
- USP affiliated authors: KALIL FILHO, JORGE ELIAS - FM ; KALLAS, ESPER GEORGES - FM
- Unidade: FM
- DOI: 10.1128/JVI.00867-17
- Subjects: DENGUE; VACINAS; ANTICORPOS; VACINAÇÃO
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Publisher place: Washington
- Date published: 2017
- Source:
- Título: Journal of virology
- ISSN: 0022-538X
- Volume/Número/Paginação/Ano: v. 91, n. 22, article ID UNSP e00867-17, 12p, 2017
- Status:
- Artigo possui acesso gratuito no site do editor (Bronze Open Access)
- Versão do Documento:
- Versão publicada (Published version)
- Acessar versão aberta:
-
ABNT
MAGNANI, Diogo M. e KALIL FILHO, Jorge Elias e KALLÁS, Esper Georges. Potent Plasmablast-Derived Antibodies Elicited by the National Institutes of Health Dengue Vaccine. Journal of virology, v. 91, n. 22, 2017Tradução . . Disponível em: https://doi.org/10.1128/JVI.00867-17. Acesso em: 01 abr. 2026. -
APA
Magnani, D. M., Kalil Filho, J. E., & Kallás, E. G. (2017). Potent Plasmablast-Derived Antibodies Elicited by the National Institutes of Health Dengue Vaccine. Journal of virology, 91( 22). doi:10.1128/JVI.00867-17 -
NLM
Magnani DM, Kalil Filho JE, Kallás EG. Potent Plasmablast-Derived Antibodies Elicited by the National Institutes of Health Dengue Vaccine [Internet]. Journal of virology. 2017 ; 91( 22):[citado 2026 abr. 01 ] Available from: https://doi.org/10.1128/JVI.00867-17 -
Vancouver
Magnani DM, Kalil Filho JE, Kallás EG. Potent Plasmablast-Derived Antibodies Elicited by the National Institutes of Health Dengue Vaccine [Internet]. Journal of virology. 2017 ; 91( 22):[citado 2026 abr. 01 ] Available from: https://doi.org/10.1128/JVI.00867-17 - CD4+ T-cell activation impairs serogroup C Neisseria meningitis vaccine response in HIV-infected children
- Invariant natural killer T cells in patients with common variable immunodeficiency [Carta]
- Safety and immunogenicity of the tetravalent, live-attenuated dengue vaccine Butantan-DV in adults in Brazil: a two-step, double-blind, randomised placebo-controlled phase 2 trial
- A pre-vaccination immune metabolic interplay determines the protective antibody response to a dengue virus vaccine
- Expansion of a subset of CD14highCD16negCCR2low/neg monocytes functionally similar to myeloid-derived suppressor cells during SIV and HIV infection
- CD57 Expression and Cytokine Production by T Cells in Lesional and Unaffected Skin from Patients with Psoriasis
- IVIg Immune Reconstitution Treatment Alleviates the State of Persistent Immune Activation and Suppressed CD4 T Cell Counts in CVID
- The CD8+ Memory Stem T Cell (TSCM) Subset Is Associated with Improved Prognosis in Chronic HIV-1 Infection
- Short Communication: HIV Type 1 Subtype BF Leads to Faster CD4+ T Cell Loss Compared to Subtype B
- Plasmablast Expansion Following the Tetravalent, Live-Attenuated Dengue Vaccine Butantan-DV in DENV-Naive and DENV-Exposed Individuals in a Brazilian Cohort
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
Por se tratar de integração com serviço externo, podem existir diferentes versões do trabalho (como preprints ou postprints), que podem diferir da versão publicada.
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
